Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jul, 2017 | Pages:
112 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Erectile Dysfunction - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Erectile Dysfunction - Pipeline Review, H2 2017, provides an overview of the Erectile Dysfunction (Male Health) pipeline landscape. Erectile dysfunction, or ED, is the inability of a man to have an erection hard enough to have sexual intercourse. It can also be known as impotence. The predisposing factors include tobacco usage, overweight, injuries, drug and alcohol use and medications, including antidepressants, antihistamines and medications to treat high blood pressure, pain or prostate cancer. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Erectile Dysfunction - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Erectile Dysfunction (Male Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Erectile Dysfunction (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Erectile Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 2, 4, 5, 3, 2, 13, 3 and 2 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 1 and 1 molecules, respectively. Erectile Dysfunction (Male Health) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data. Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Erectile Dysfunction (Male Health). - The pipeline guide reviews pipeline therapeutics for Erectile Dysfunction (Male Health) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Erectile Dysfunction (Male Health) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Erectile Dysfunction (Male Health) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Erectile Dysfunction (Male Health) Reasons To Buy - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Erectile Dysfunction (Male Health). - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Erectile Dysfunction (Male Health) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Table of Contents 2 List of Tables 5 List of Figures 6 Introduction 7 Global Markets Direct Report Coverage 7 Erectile Dysfunction - Overview 8 Erectile Dysfunction - Therapeutics Development 9 Pipeline Overview 9 Pipeline by Companies 10 Pipeline by Universities/Institutes 13 Products under Development by Companies 14 Products under Development by Universities/Institutes 16 Erectile Dysfunction - Therapeutics Assessment 17 Assessment by Target 17 Assessment by Mechanism of Action 19 Assessment by Route of Administration 21 Assessment by Molecule Type 23 Erectile Dysfunction - Companies Involved in Therapeutics Development 25 Apricus Biosciences Inc 25 Astellas Pharma Inc 25 Biolab Farmaceutica Ltda 26 Biopharm GmbH 26 Can-Fite BioPharma Ltd 27 Fabre-Kramer Pharmaceuticals Inc 27 Futura Medical Plc 28 Hanmi Pharmaceuticals Co Ltd 28 Humanetics Corp 29 IntelGenx Corp 29 Ion Channel Innovations LLC 30 iX Biopharma Ltd 30 Mezzion Pharma Co Ltd 31 Mitsubishi Tanabe Pharma Corp 31 Monosol Rx LLC 32 N4 Pharma Plc 32 NAL Pharmaceuticals Ltd 33 Nanoform Cardiovascular Therapeutics Ltd 33 Palatin Technologies Inc 34 Pharmicell Co Ltd 34 SK Chemicals Co Ltd 35 Suda Ltd 35 XuanZhu Pharma Co Ltd 36 Yangtze River Pharmaceutical Group 36 Yungjin Pharm Co Ltd 37 Erectile Dysfunction - Drug Profiles 38 alprostadil - Drug Profile 38 AP-185 - Drug Profile 45 avanafil - Drug Profile 46 BIO-300 - Drug Profile 48 BL-214 - Drug Profile 51 Cellgram-ED - Drug Profile 52 CF-602 - Drug Profile 53 fadanafil - Drug Profile 55 FKK-01PD - Drug Profile 56 HCP-1302 - Drug Profile 57 IPED-2015 - Drug Profile 58 MED-2002 - Drug Profile 59 MED-2005 - Drug Profile 62 mirabegron ER - Drug Profile 63 moxisylyte - Drug Profile 67 Peptide to Activate G Protein-Coupled Receptor Mas for Cardiovascular, Metabolic Disorders and Male Health - Drug Profile 68 pVAX-hSlo - Drug Profile 70 Recombinant Protein for Bone Fracture, Degenerative Disc Disease, Erectile Dysfunction and Parkinson's Disease - Drug Profile 72 sildenafil - Drug Profile 74 sildenafil citrate - Drug Profile 75 sildenafil citrate - Drug Profile 76 sildenafil citrate - Drug Profile 77 sildenafil citrate - Drug Profile 78 Small Molecule to Inhibit PDE5 for Erectile Dysfunction - Drug Profile 79 SUD-003 - Drug Profile 80 Synthetic Peptide to Agonize Melanocortin 4 Receptor for Female Sexual Dysfunction and Erectile Dysfunction - Drug Profile 82 T-6932 - Drug Profile 83 tadalafil - Drug Profile 84 tadalafil - Drug Profile 86 tadalafil - Drug Profile 87 tadalafil - Drug Profile 88 tadalafil - Drug Profile 89 TF-0092 - Drug Profile 90 TPN-729 - Drug Profile 91 TR-399 - Drug Profile 92 udenafil - Drug Profile 93 YBH-1603 - Drug Profile 97 Yonkenafil - Drug Profile 98 Erectile Dysfunction - Dormant Projects 99 Erectile Dysfunction - Discontinued Products 101 Erectile Dysfunction - Product Development Milestones 102 Featured News & Press Releases 102 Appendix 109 Methodology 109 Coverage 109 Secondary Research 109 Primary Research 109 Expert Panel Validation 109 Contact Us 109 Disclaimer 110
List of Tables
Number of Products under Development for Erectile Dysfunction, H2 2017 Number of Products under Development by Companies, H2 2017 Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017 Number of Products under Development by Universities/Institutes, H2 2017 Products under Development by Companies, H2 2017 Products under Development by Companies, H2 2017 (Contd..1), H2 2017 Products under Development by Universities/Institutes, H2 2017 Number of Products by Stage and Target, H2 2017 Number of Products by Stage and Mechanism of Action, H2 2017 Number of Products by Stage and Route of Administration, H2 2017 Number of Products by Stage and Molecule Type, H2 2017 Erectile Dysfunction - Pipeline by Apricus Biosciences Inc, H2 2017 Erectile Dysfunction - Pipeline by Astellas Pharma Inc, H2 2017 Erectile Dysfunction - Pipeline by Biolab Farmaceutica Ltda, H2 2017 Erectile Dysfunction - Pipeline by Biopharm GmbH, H2 2017 Erectile Dysfunction - Pipeline by Can-Fite BioPharma Ltd, H2 2017 Erectile Dysfunction - Pipeline by Fabre-Kramer Pharmaceuticals Inc, H2 2017 Erectile Dysfunction - Pipeline by Futura Medical Plc, H2 2017 Erectile Dysfunction - Pipeline by Hanmi Pharmaceuticals Co Ltd, H2 2017 Erectile Dysfunction - Pipeline by Humanetics Corp, H2 2017 Erectile Dysfunction - Pipeline by IntelGenx Corp, H2 2017 Erectile Dysfunction - Pipeline by Ion Channel Innovations LLC, H2 2017 Erectile Dysfunction - Pipeline by iX Biopharma Ltd, H2 2017 Erectile Dysfunction - Pipeline by Mezzion Pharma Co Ltd, H2 2017 Erectile Dysfunction - Pipeline by Mitsubishi Tanabe Pharma Corp, H2 2017 Erectile Dysfunction - Pipeline by Monosol Rx LLC, H2 2017 Erectile Dysfunction - Pipeline by N4 Pharma Plc, H2 2017 Erectile Dysfunction - Pipeline by NAL Pharmaceuticals Ltd, H2 2017 Erectile Dysfunction - Pipeline by Nanoform Cardiovascular Therapeutics Ltd, H2 2017 Erectile Dysfunction - Pipeline by Palatin Technologies Inc, H2 2017 Erectile Dysfunction - Pipeline by Pharmicell Co Ltd, H2 2017 Erectile Dysfunction - Pipeline by SK Chemicals Co Ltd, H2 2017 Erectile Dysfunction - Pipeline by Suda Ltd, H2 2017 Erectile Dysfunction - Pipeline by XuanZhu Pharma Co Ltd, H2 2017 Erectile Dysfunction - Pipeline by Yangtze River Pharmaceutical Group, H2 2017 Erectile Dysfunction - Pipeline by Yungjin Pharm Co Ltd, H2 2017 Erectile Dysfunction - Dormant Projects, H2 2017 Erectile Dysfunction - Dormant Projects, H2 2017 (Contd..1), H2 2017 Erectile Dysfunction - Discontinued Products, H2 2017
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
